Skip to main content

Anna Sandström Gerdtsson

The advent of immunotherapy has resulted in significant survival benefits in cancer care. The immune response is however heterogeneous across tumors and individuals, rendering existing therapeutics non-effective for many patients. My research focuses on identification of biomarker signatures for patient stratification and new treatment strategies through comprehensive characterization of the tumor immune microenvironment.

Anna Sandström Gerdtsson. Portrait.

Anna Sandström Gerdtsson

anna.sandstrom_gerdtsson@immun.lth.se
+46-46-222-9678

Department of Immunotechnology
Lund University
Medicon Village; Bldg 406
223 81 Lund, Sweden

Page Manager: jana.hladilkova@immun.lth.se | 2021-08-19